Adverse drug reaction-related hospitalisations - A nationwide study in The Netherlands

被引:135
|
作者
van der Hooft, CS
Sturkenboom, MCJM
van Grootheest, K
Kingma, HJ
Stricker, BHC
机构
[1] Erasmus Univ, Dept Epidemiol & Biostat, Med Ctr, Pharmacoepidemiol Unit, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Dept Med Informat, Med Ctr, NL-3000 DR Rotterdam, Netherlands
[3] Netherlands Pharmacovigilance Ctr Lareb, Shertogenbosch, Netherlands
关键词
D O I
10.2165/00002018-200629020-00006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The incidence of adverse drug reaction (ADR)-related hospitalisations has usually been assessed within hospitals. Because of the variability in results and methodology, it is difficult to extrapolate these results to a national level. Objectives: To evaluate the incidence and characteristics of ADR-related hospitalisations in The Netherlands in 2001. Methods: We conducted a nationwide study of all hospital admissions in 2001. Data were retrieved from a nationwide computer database for hospital discharge records. All acute, non-planned admissions to all Dutch academic and general hospitals in 2001 were included in the study (n = 668 714). From these admissions we selected all hospitalisations that were coded as drug-related, but intended forms of overdose, errors in administration and therapeutic failures were excluded. Hence, we extracted all ADR-related hospitalisations. We compared age, sex and the risk of a fatal outcome between patients admitted with ADRs and patients admitted for other reasons, as well as the most frequent main diagnoses in ADR-related hospitalisations and which drugs most frequently caused the ADRs. In addition, we evaluated to what extent these ADRs were reported to the Netherlands Pharmacovigilance Centre Lareb for spontaneous ADR reporting. Results: In 2001, 12 249 hospitalisations were coded as ADR related. This was 1.83% of all acute hospital admissions in The Netherlands (95% CI 1.80, 1.86). The proportion increased with age from 0.8% (95% CI 0.75,0.85) in the < 18 years group to 3.2% in the >= 80 years group (95% CI 3.08, 3.32). The most frequent ADR-related diagnoses of hospital isation s were bleeding (n = 1048), non-specified 'unintended effect of drug' (n = 438), hypoglycaemia (n = 375) and fever (n = 347). The drugs most commonly associated with ADR-related hospitalisations were anticoagulants (n = 2185), cytostatics and immuncisuppressives (n = 1809) and diuretics (n = 979). Six percent of the ADR-related hospitalisations had a fatal outcome (n = 734). Older age and female gender were associated with ADR-related hospital is ations. Only approximately 1% of the coded ADRs causing hospitalisation were reported to our national centre for spontaneous ADR reporting. Conclusion: The proportion of ADR-related hospitalisations is substantial, especially considering the fact that not all ADRs may be recognised or mentioned in discharge letters. Under-reporting of ADRs that result in hospital admission to our national centre for spontaneous ADR reporting was considerable.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 50 条
  • [1] Adverse Drug Reaction-Related HospitalisationsA Nationwide Study in The Netherlands
    Cornelis S. van der Hooft
    Miriam C.J.M. Sturkenboom
    Kees van Grootheest
    Herre J. Kingma
    Bruno H.Ch. Stricker
    [J]. Drug Safety, 2006, 29 : 161 - 168
  • [2] Adverse drug reaction-related hospitalisations: a population-based cohort study
    van der Hooft, Cornelis S.
    Dieleman, Jeanne P.
    Siemes, Claire
    Aarnoudse, Albert-Jan L. H. J.
    Verhamme, Katia M. C.
    Stricker, Bruno H. C. H.
    Sturkenboom, Miriam C. J. M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (04) : 365 - 371
  • [3] Predictors of Adverse Drug Reaction-Related Hospitalisations Among People with Dementia: A Retrospective Case-Control Study
    Zaidi, Anum Saqib
    Peterson, Gregory M.
    Curtain, Colin M.
    Salahudeen, Mohammed S.
    [J]. DRUG SAFETY, 2024, 47 (08) : 771 - 781
  • [4] Trends in adverse drug reaction-related hospitalisations over 13 years in New South Wales, Australia
    Zhang, Hanwen
    Du, Wei
    Gnjidic, Danijela
    Chong, Shanley
    Glasgow, Nicholas
    [J]. INTERNAL MEDICINE JOURNAL, 2019, 49 (01) : 84 - 93
  • [5] Adverse drug reaction-related hospitalisations among patients with heart failure at two hospitals in the United Arab Emirates
    Narjes Saheb Sharif-Askari
    Syed Azhar Syed Sulaiman
    Fatemeh Saheb Sharif-Askari
    Ali Al Sayed Hussain
    [J]. International Journal of Clinical Pharmacy, 2015, 37 : 105 - 112
  • [6] Adverse drug reaction-related hospitalisations among patients with heart failure at two hospitals in the United Arab Emirates
    Sharif-Askari, Narjes Saheb
    Sulaiman, Syed Azhar Syed
    Sharif-Askari, Fatemeh Saheb
    Hussain, Ali Al Sayed
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 105 - 112
  • [7] Adverse Drug Reaction-Related Hospitalizations in Persons Aged 55 Years and Over: A Population-Based Study in the Netherlands
    Ruiter, Rikje
    Visser, Loes E.
    Rodenburg, Eline M.
    Trifiro, Gianluca
    Ziere, Gijsbertus
    Stricker, Bruno H.
    [J]. DRUGS & AGING, 2012, 29 (03) : 225 - 232
  • [8] Adverse Drug Reaction-Related Hospitalizations in Persons Aged 55 Years and OverA Population-Based Study in the Netherlands
    Rikje Ruiter
    Loes E. Visser
    Eline M. Rodenburg
    Gianluca Trifiró
    Gijsbertus Ziere
    Bruno H. Stricker
    [J]. Drugs & Aging, 2012, 29 : 225 - 232
  • [9] Adverse drug reaction-related admissions in paediatrics, a prospective single-centre study
    Posthumus, Anke A. G.
    Alingh, Carien C. W.
    Zwaan, Christian C. M.
    van Grootheest, Kees K.
    Hanff, Lidwien L. M.
    Witjes, Bregje B. C. M.
    t'Jong, Geert W.
    de Hoog, Matthijs
    [J]. BMJ OPEN, 2012, 2 (04):
  • [10] Persistence of Adverse Drug Reaction-Related Hospitalization Risk Following Discharge
    Schmid, Olive
    Bereznicki, Bonnie
    Peterson, Gregory Mark
    Stankovich, Jim
    Bereznicki, Luke
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (09)